yhr2403
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 4, 2024 (NCT06623526)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07111468 | Phase 3 | Oct 17, 2025 | Yuhan Pharmaceutical Company |
| NCT06623526 | Phase 1 | Oct 4, 2024 | Jeonbuk National University, Yuhan Pharmaceutical Company |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yuhan Pharmaceutical Company | For profit | 2 | 2 | 2 | 2024 |
| Jeonbuk National University | Academic/Hospital | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1